4 latest FDA approvals

Here are the four latest drugs approved by the Food and Drug Administration this week.

Advertisement

1. Dupixent is intended to treat patients with moderate to severe eczema.

2. Zejula can now be used as a maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.

3. Bavencio is the first treatment for metastatic Merkel cell carcinoma, a rare form of skin cancer.

4. Ocrevus is intended to treat patients with severe forms of multiple sclerosis.

More articles on supply chain:

7 must-reads for supply chain leaders this week
America’s focus on technology — rather than medicine — is ‘eroding our national intellect,’ says pharma exec
Bill Ackman calls $4B Valeant investment ‘huge mistake’

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.